Results 21 to 30 of about 246,725 (308)

Examining dyslipidaemia, metabolic syndrome and liver enzyme levels in patients with prediabetes and type 2 diabetes in population from Hoveyzeh cohort study: A case–control study in Iran

Endocrinology, Diabetes & Metabolism, 2023
Introduction Type 2 diabetes mellitus (T2DM) is among the world's top 10 leading causes of death. Additionally, prediabetes is a major risk factor for diabetes.
Negar Dinarvand, Bahman Cheraghian, Zahra Rahimi, Samaneh Salehipour Bavarsad, Amirhooshang Bavarsad, Narges Mohammadtaghvaei   +5 more
doaj   +1 more source

Plasma kinetics of VLDL and HDL apoC-I in normolipidemic and hypertriglyceridemic subjects

Journal of Lipid Research, 2002
ApoC-I has several different lipid-regulating functions including, inhibition of receptor-mediated uptake of plasma triglyceride-rich lipoproteins, inhibition of cholesteryl ester transfer activity, and mediation of tissue fatty acid uptake. Since little
Jeffrey S. Cohn, Michel Tremblay, Rami Batal, Hélène Jacques, Lyne Veilleux, Claudia Rodriguez, Lise Bernier, Orval Mamer, Jean Davignon   +8 more
doaj   +1 more source

Relation of hyperlipidemia in serum and loss of high density lipoproteins in urine in the nephrotic syndrome [PDF]

, 1987
The mechanism leading to hyperlipidemia in the nephrotic syndrome is not fully understood but may be related in part to loss of high density lipoproteins in the urine of patients with nephrosis.
Appel, Baxter, Baxter, Chopra, De Mendoza, Eggstein, Felts, Gherardi, Gherardi, Havel, Jüngst, Jüngst, Kashyap, Klahr, Lopes-Virella, Newmark, Ohta, Röschlau, Sachs, Sata, Tamm, Wada, Weichselbaum   +22 more
core   +1 more source

Comparison of the anti-inflammatory and antilipidemic activity of diosmin and saroglitazar in a model of nonalcoholic fatty liver induced by a high-fat diet in Wistar rats [PDF]

Iranian Journal of Basic Medical Sciences
Objective(s): Non-alcoholic fatty liver disease (NAFLD) is the most common liver-related metabolic disorder in the world, with a global prevalence of 25%.
Reza Afarin, Negar Dinarvand, Bahar Jaberian Asl, Ghazal Orak, Elham Shakerian, Fatemeh Bineshfar, Akram Ahangarpour   +6 more
doaj   +1 more source

Impact of modifiable risk factors on prediction of 10-year cardiovascular disease utilizing framingham risk score in Southwest Iran

BMC Cardiovascular Disorders, 2023
Background This cohort study was conducted to examine the association between modifiable risk factors, including hypertension, smoking, physical activity, diabetes, cholesterol, and high-density lipoprotein with Framingham risk score in the prediction of
Nader Saki, Hossein Babaahmadi-Rezaei, Zahra Rahimi, Maedeh Raeisizadeh, Fateme Jorfi, Faeze Seif, Bahman Cheraghian, Hossien Ghaderi-Zefrehi, Maryam Rezaei   +8 more
doaj   +1 more source

Systematic review and network meta-analysis on the efficacy of evolocumab and other therapies for the management of lipid levels in hyperlipidemia [PDF]

, 2017
Background: The proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors evolocumab and alirocumab substantially reduce low‐density lipoprotein cholesterol (LDL‐C) when added to statin therapy in patients who need additional LDL‐C reduction ...
Bray, Sarah, Bridges, Ian, Cheng, Lung-I, Dent, Ricardo, Deshpande, Sohan, Forbes, Carol A., Gandra, Shravanthi R., Kleijnen, Jos, Ross, Janine, Sattar, Naveed, Stroes, Erik S.G., Toth, Peter P., Worth, Gavin M., Worthy, Gillian   +13 more
core   +1 more source

In vitro factors affecting the concentration of gamma-LpE (γ-LpE) in human plasma

Journal of Lipid Research, 1998
Gamma-LpE (γ-LpE), a sphingomyelin-rich lipoprotein that contains apolipoprotein (apo) E as its only protein component, has been proposed to play a role in cellular cholesterol efflux by acting, like pre-β1-LpA-I, as an initial acceptor of cell-derived ...
Larbi Krimbou, Michel Tremblay, Hélène Jacques, Jean Davignon, Jeffrey S. Cohn   +4 more
doaj   +1 more source

Characterization of remnant-like particles isolated by immunoaffinity gel from the plasma of type III and type IV hyperlipoproteinemic patients

Journal of Lipid Research, 1999
Previous studies have investigated the potential atherogenicity and thrombogenicity of triglyceride-rich lipoprotein (TRL) remnants by isolating them from plasma within a remnant-like particle (RLP) fraction, using an immunoaffinity gel containing ...
Caroline Marcoux, Michel Tremblay, Katsuyuki Nakajima, Jean Davignon, Jeffrey S. Cohn   +4 more
doaj   +1 more source

Public Perspective on Hyperlipidemia Drugs and Sentiments About Hyperlipidemia on Twitter

Borneo Journal of Pharmacy, 2023
Hyperlipidemia is a non-communicable disease (NCD) caused by several factors, such as a person's socioeconomic status, culture, customs, habits, and lifestyle.
Murojil Hasan, Chairun Wiedyaningsih, Nanang Munif Yasin   +2 more
doaj   +2 more sources

Association of apolipoprotein E with α2-macroglobulin in human plasma

Journal of Lipid Research, 1998
Apolipoprotein (apo) E plays a central role in the transport of lipids among different organs and cell types, whereas α2-macroglobulin (α2M) is responsible for the binding and inactivation of plasma proteases, as well as the transport of various ...
Larbi Krimbou, Michel Tremblay, Jean Davignon, Jeffrey S. Cohn   +3 more
doaj   +1 more source